mRNA |
ML083 |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.04 |
mRNA |
PF-4800567 hydrochloride |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.04 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.04 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.04 |
mRNA |
RAF265 |
CCLE |
pan-cancer |
AAC |
-0.1 |
0.04 |
mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.04 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.04 |
mRNA |
ifosfamide |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.04 |
mRNA |
17-AAG |
CCLE |
pan-cancer |
AAC |
-0.094 |
0.04 |
mRNA |
CIL56 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.04 |